Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of Medicinal Chemistry|December 9, 2023
AcGlcAs: A Novel P53-Targeting Arsenical with Potent Cellular Uptake and Cancer Cell SelectivityYing Liang, Quanlin An, Huaxin Song, et al.Current Eye Research|February 1, 2017
Efficacy of Purtscher's Retinopathy Treatments: A Systematic ReviewDuosheng Xia, Xiaomei Chen, Qi Zhou, et al.American Journal of Translational Research|May 21, 2021
Correlation of CD3+/CD4+, and serum CK-18 fragment levels with glucose and lipid metabolism in elderly type 2 diabetes patients with nonalcoholic fatty liver diseaseChunzhi Zhao, Fangyong Lou, Xing Li, et al.Fundamental Research|August 1, 2026
p53 mutation-associated prognosis across cancer types underlines hematological malignancy as an applicable cancer type to p53-rescue therapyShujun Xiao, Jiaqi Wu, Kai Tan, et al.EMBO Reports|April 4, 2022
Developmental arsenic exposure impairs cognition, directly targets DNMT3A, and reduces DNA methylationNi Yan, Yuntong Li, Yangfei Xing, et al.Clinical and Experimental Rheumatology|January 24, 2020
Recommendations in clinical practice guidelines on gout: systematic review and consistency analysisYang Yu, Dongke Wang, Qi Zhou, et al.Cancer Cell|February 25, 2024
Characterization of the generic mutant p53-rescue compounds in a broad range of assaysShujun Xiao, Fangfang Shi, Huaxin Song, et al.Cell Reports. Medicine|February 22, 2025
Pharmacological rescue of mutant p53 triggers spontaneous tumor regression via immune responsesJiabing Li, Shuang Zhang, Baohui Wang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 26, 2025
RIG-I-Inducing Small Molecules Potently Inhibit HMA-Resistant AML Through Igniting the Overloaded dsRNA ArsenalXueqin Chen, Jiaqi Wu, Yuntong Li, et al.Science Translational Medicine|April 5, 2023
Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational propertiesHuaxin Song, Jiale Wu, Yigang Tang, et al.Pageof 3